$DGX Income Statement | Understand Stock

$DGX

$242.95 +$1.06 (0.44%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net revenues
Operating costs and expenses and other operating income:
Cost of services
Selling, general and administrative
Amortization of intangible assets
Other operating (income) expense, net
Total operating costs and expenses, net
Operating income
Other income (expense):
Interest expense, net
Other Nonoperating Income (Expense)
Total non-operating expense, net
Income before income taxes and equity in earnings of equity method investees
Income tax expense
Equity in earnings of equity method investees, net of taxes
Income from continuing operations
Income from discontinued operations, net of taxes
Net income
Less: Net income attributable to noncontrolling interests
Net income attributable to Quest Diagnostics
Income from continuing operations (in dollars per share)
Income from discontinued operations (in dollars per share)
Earnings per share attributable to Quest Diagnostics’ common stockholders:
Basic (in dollars per share)
Income from continuing operations (in dollars per share)
Income from discontinued operations (in dollars per share)
Diluted (in dollars per share)

Comments